A deep carbon footprint is a common hallmark of energy intensive manufacturing processes. The manufacture of pharmaceuticals is no exception. However, emissions levels can be reduced by adopting a sustainable approach to process efficiency, energy generation and energy procurement.
In this white paper, sector experts explore ways in which pharmaceutical manufacturers can:
- Reduce carbon emissions
- Increase profitability
- Enhance operational resilience
- Support a dynamic grid system